Lesinidase alfa Uses, Dosage, Side Effects and more
Lesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).
| Trade Name | Lesinidase alfa |
| Generic | Lesinidase alfa |
| Lesinidase alfa Other Names | Lesinidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
